Colorectal Cancer


The science is clear. If Americans received regular screenings for colorectal cancer, thousands of deaths could be prevented each year. But, for too many Americans, the screenings either aren't fully covered by their health insurance or aren’t affordable due to high out-of-pocket costs. 

The 80% by 2018 campaign strives to pass state and federal laws that remove the barriers preventing people from getting colonoscopies and other lifesaving colorectal cancer screenings. 

Colorectal cancer is the second leading cause of cancer death in the U.S. for men and women combined.

Latest Updates

January 11, 2022

New guidance from the Tri-Agencies (Department of Labor, Department of Health and Human Services, Treasury) announced late Monday says private insurance plans must now cover follow-up colonoscopies after a positive non-invasive stool test.

January 4, 2022

INDIANAPOLIS, IN – As lawmakers dive into the 2022 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize improving access to colorectal cancer screenings and increasing the state’s tobacco taxes, both of which will ease the burden of cancer on Hoosiers. “We know that

September 29, 2021
Rhode Island

PROVIDENCE – Senate Majority Whip Maryellen Goodwin and House Deputy Majority Whip Mia Ackerman each received the National Distinguished Advocacy Award this week, the most prestigious award presented by the American Cancer Society Cancer Action Network (ACS CAN), in recognition of their significant contributions to the fight against cancer.

September 1, 2021

Beginning today, Texans 45 and older will have coverage for colorectal cancer screening, per a new state law that updates the age for such lifesaving screenings from 50 to 45 in accordance with

Colorectal Cancer Resources

ACS CAN's comments in response to the calendar year (CY) 2022 Medicare Physician Fee Schedule proposed rule focused on two issues:

1. whether HHS should create a separate code for pain management activities, and

Colorectal cancer is the third most common cancer in men and women and the second leading cause of cancer death in men and women combined in the United States. Yet, about 1 in 3 adults aged 50 to 75 are not getting tested as recommended. This factsheet discusses the importance of screening for colorectal cancer and what can be done to improve screening in the U.S.


An estimated 149,500 men and women will be diagnosed with colorectal cancer in 2021 and 52,980 individuals are estimated to die from the disease. Without a continued, dedicated federal investment in colorectal cancer prevention and early detection, the U.S. could experience a reduction in screening leading to increases in completely preventable colorectal cancer cases and deaths. This factsheet discusses the importance of continued funding for the Colorectal Cancer Control Program (CRCCP).